CHM and choroideremia: There is considerable evidence for a role of rod dysfunction in CHM, including the preferential loss of rods in a female CHM carrier [42], early changes in CHM tending to occur in the peripheral more rod-rich regions [43] and spectral domain-optical coherence tomography evidence of rod OS abnormalities, most likely OS shortening, that precede retinal remodelling [44].